{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:38:26Z","timestamp":1784551106845,"version":"3.55.0"},"reference-count":38,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2022,10,16]],"date-time":"2022-10-16T00:00:00Z","timestamp":1665878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Ministry of Science and Technology, Taiwan","award":["MOST 109-2314-B-195-003-MY3"],"award-info":[{"award-number":["MOST 109-2314-B-195-003-MY3"]}]},{"name":"the Ministry of Science and Technology, Taiwan","award":["MOST 108-2320-B-039-023-MY3"],"award-info":[{"award-number":["MOST 108-2320-B-039-023-MY3"]}]},{"name":"the Ministry of Science and Technology, Taiwan","award":["MOST 109-2811-B-039-510"],"award-info":[{"award-number":["MOST 109-2811-B-039-510"]}]},{"name":"the Ministry of Science and Technology, Taiwan","award":["MMH-E-110-13"],"award-info":[{"award-number":["MMH-E-110-13"]}]},{"name":"the Ministry of Science and Technology, Taiwan","award":["DMR-110-135"],"award-info":[{"award-number":["DMR-110-135"]}]},{"name":"MacKay Memorial Hospital, Taipei, Taiwan","award":["MOST 109-2314-B-195-003-MY3"],"award-info":[{"award-number":["MOST 109-2314-B-195-003-MY3"]}]},{"name":"MacKay Memorial Hospital, Taipei, Taiwan","award":["MOST 108-2320-B-039-023-MY3"],"award-info":[{"award-number":["MOST 108-2320-B-039-023-MY3"]}]},{"name":"MacKay Memorial Hospital, Taipei, Taiwan","award":["MOST 109-2811-B-039-510"],"award-info":[{"award-number":["MOST 109-2811-B-039-510"]}]},{"name":"MacKay Memorial Hospital, Taipei, Taiwan","award":["MMH-E-110-13"],"award-info":[{"award-number":["MMH-E-110-13"]}]},{"name":"MacKay Memorial Hospital, Taipei, Taiwan","award":["DMR-110-135"],"award-info":[{"award-number":["DMR-110-135"]}]},{"name":"China Medical University Hospital, Taichung Taiwan","award":["MOST 109-2314-B-195-003-MY3"],"award-info":[{"award-number":["MOST 109-2314-B-195-003-MY3"]}]},{"name":"China Medical University Hospital, Taichung Taiwan","award":["MOST 108-2320-B-039-023-MY3"],"award-info":[{"award-number":["MOST 108-2320-B-039-023-MY3"]}]},{"name":"China Medical University Hospital, Taichung Taiwan","award":["MOST 109-2811-B-039-510"],"award-info":[{"award-number":["MOST 109-2811-B-039-510"]}]},{"name":"China Medical University Hospital, Taichung Taiwan","award":["MMH-E-110-13"],"award-info":[{"award-number":["MMH-E-110-13"]}]},{"name":"China Medical University Hospital, Taichung Taiwan","award":["DMR-110-135"],"award-info":[{"award-number":["DMR-110-135"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Daphnoretin extracted from the stem and roots of Wikstroemia indica (L.) C.A. Mey has been shown to possess antiviral and antitumor activities. Herein, we hypothesized that daphnoretin might induce megakaryocytic differentiation, thereby inhibiting the proliferation of cells and serving as a differentiation therapy agent for chronic myeloid leukemia (CML). Daphnoretin-treated K562 and HEL cells were examined for growth inhibition, cell morphology, and megakaryocyte-specific markers. Potential mechanisms of megakaryocytic differentiation of daphnoretin-treated K562 cells were evaluated. The results showed that daphnoretin inhibited the growth of K562 and HEL cells in a dose- and time-dependent manner. Flow cytometry analyses revealed that daphnoretin treatment slightly increased the proportion of sub-G1 and polyploid cells compared to that of dimethyl sulfoxide (DMSO)-treated control cells. Morphological examination showed that daphnoretin-treated K562 and HEL cells exhibited enlarged contours and multinucleation as megakaryocytic characteristics compared to DMSO-treated control cells. Daphnoretin treatment also dramatically enhanced the expression of megakaryocytic markers CD61 and CD41. Under optimal megakaryocytic differentiation conditions, daphnoretin increased the phosphorylation of STAT3 but not STAT5. In summary, daphnoretin inhibited cell growth and induced megakaryocytic differentiation in K562 and HEL cells. The efficacy of daphnoretin in vivo and in patients with CML may need further investigations for validation.<\/jats:p>","DOI":"10.3390\/cells11203252","type":"journal-article","created":{"date-parts":[[2022,10,16]],"date-time":"2022-10-16T21:10:10Z","timestamp":1665954610000},"page":"3252","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Naturally Occurring Bicoumarin Compound Daphnoretin Inhibits Growth and Induces Megakaryocytic Differentiation in Human Chronic Myeloid Leukemia Cells"],"prefix":"10.3390","volume":"11","author":[{"given":"Yu-Chuen","family":"Huang","sequence":"first","affiliation":[{"name":"School of Chinese Medicine, China Medical University, Taichung 40402, Taiwan"},{"name":"Department of Medical Research, China Medical University Hospital, Taichung 40447, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3363-964X","authenticated-orcid":false,"given":"Chun-Ping","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Chinese Medicine, China Medical University, Taichung 40402, Taiwan"},{"name":"Integration Center of Traditional Chinese and Modern Medicine, Department of Chinese Medicine, Hualien Tzu Chi Hospital, Hualien 97002, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Ping","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Medical Research, MacKay Memorial Hospital, New Taipei City 25160, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Chien","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Medical Research, MacKay Memorial Hospital, New Taipei City 25160, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jie","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Medical Research, China Medical University Hospital, Taichung 40447, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Pei","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Chinese Medicine, China Medical University, Taichung 40402, Taiwan"},{"name":"Department of Public Health, China Medical University, Taichung 40402, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5935-6755","authenticated-orcid":false,"given":"Yueh-Hsiung","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Medical Research, China Medical University Hospital, Taichung 40447, Taiwan"},{"name":"Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung 40402, Taiwan"},{"name":"Department of Biotechnology, Asia University, Taichung 41354, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Medical Research, China Medical University Hospital, Taichung 40447, Taiwan"},{"name":"Department of Medical Research, MacKay Memorial Hospital, New Taipei City 25160, Taiwan"},{"name":"Department of Radiation Oncology, MacKay Memorial Hospital, Taipei 10449, Taiwan"},{"name":"Department of Artificial Intelligence and Medical Application, MacKay Junior College of Medicine, Nursing and Management, Taipei 11260, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1200\/JCO.2010.29.8711","article-title":"Myeloproliferative neoplasms: Molecular pathophysiology, essential clinical understanding, and treatment strategies","volume":"29","author":"Tefferi","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1182\/blood-2008-10-184960","article-title":"Failure to achieve a complete hematologic response at the time of a major cytogenetic response with second-generation tyrosine kinase inhibitors is associated with a poor prognosis among patients with chronic myeloid leukemia in accelerated or blast phase","volume":"113","author":"Fava","year":"2009","journal-title":"Blood"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3389\/fonc.2019.01132","article-title":"Management of Chronic Myeloid Leukemia in Advanced Phase","volume":"9","author":"Bonifacio","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrc2943","article-title":"Acute promyelocytic leukaemia: Novel insights into the mechanisms of cure","volume":"10","author":"Chen","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrc.2017.103","article-title":"Differentiation therapy revisited","volume":"18","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Yen, J.H., Lin, C.Y., Chuang, C.H., Chin, H.K., Wu, M.J., and Chen, P.Y. (2020). Nobiletin Promotes Megakaryocytic Differentiation through the MAPK\/ERK-Dependent EGR1 Expression and Exerts Anti-Leukemic Effects in Human Chronic Myeloid Leukemia (CML) K562 Cells. Cells, 9.","DOI":"10.3390\/cells9040877"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ccell.2019.07.010","article-title":"The Dual Roles of the Atypical Protein Kinase Cs in Cancer","volume":"36","author":"Moscat","year":"2019","journal-title":"Cancer Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ijc.2910180405","article-title":"Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia","volume":"18","author":"Klein","year":"1976","journal-title":"Int. J. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.6177045","article-title":"HEL cells: A new human erythroleukemia cell line with spontaneous and induced globin expression","volume":"216","author":"Martin","year":"1982","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1182\/blood.V62.4.832.832","article-title":"Human erythroleukemia cell line (HEL) undergoes a drastic macrophage-like shift with TPA","volume":"62","author":"Papayannopoulou","year":"1983","journal-title":"Blood"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0145-2126(90)90002-Q","article-title":"Induced differentiation of K562 leukemia cells: A model for studies of gene expression in early megakaryoblasts","volume":"14","author":"Alitalo","year":"1990","journal-title":"Leuk. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1172\/JCI114538","article-title":"Regulation of megakaryocyte phenotype in human erythroleukemia cells","volume":"85","author":"Long","year":"1990","journal-title":"J. Clin. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2141.2006.06215.x","article-title":"Megakaryocyte development and platelet production","volume":"134","author":"Deutsch","year":"2006","journal-title":"Br. J. Haematol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1538-7836.2009.03658.x","article-title":"The mitogen-activated protein kinase signaling pathways: Role in megakaryocyte differentiation","volume":"8","author":"Ghevaert","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1196\/annals.1349.018","article-title":"Thrombopoietin and the hematopoietic stem cell","volume":"1044","author":"Kaushansky","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1055\/s-0038-1642732","article-title":"Thrombopoietin: The primary regulator of megakaryocyte and platelet production","volume":"74","author":"Kaushansky","year":"1995","journal-title":"Thromb. Haemost."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1021\/np50002a004","article-title":"(+)-Nortrachelogenin, a new pharmacologically active lignan from Wikstroemia indica","volume":"42","author":"Kato","year":"1979","journal-title":"J. Nat. Prod."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2174\/138920109789978748","article-title":"Bioactive components and pharmacological action of Wikstroemia indica (L.) C. A. Mey and its clinical application","volume":"10","author":"Li","year":"2009","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1021\/np50017a003","article-title":"Antitumor agents. 49 tricin, kaempferol-3-O-beta-D-glucopyranoside and (+)-nortrachelogenin, antileukemic principles from Wikstroemia indica","volume":"44","author":"Lee","year":"1981","journal-title":"J. Nat. Prod."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0006-2952(96)00420-0","article-title":"Identification of a protein kinase C (PKC) activator, daphnoretin, that suppresses hepatitis B virus gene expression in human hepatoma cells","volume":"52","author":"Chen","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/bj2950321","article-title":"Daphnoretin, a new protein kinase C activator isolated from Wikstroemia indica C.A. Mey","volume":"295","author":"Ko","year":"1993","journal-title":"Biochem. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.intimp.2017.07.021","article-title":"Daphnoretin modulates differentiation and maturation of human dendritic cells through down-regulation of c-Jun N-terminal kinase","volume":"51","author":"Chen","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/jps.2600710706","article-title":"Antitumor agents LIII: The effects of daphnoretin on nucleic acid and protein synthesis of Ehrlich ascites tumor cells","volume":"71","author":"Hall","year":"1982","journal-title":"J. Pharm. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Sarno, F., Pepe, G., Termolino, P., Carafa, V., Massaro, C., Merciai, F., Campiglia, P., Nebbioso, A., and Altucci, L. (2020). Trifolium Repens Blocks Proliferation in Chronic Myelogenous Leukemia via the BCR-ABL\/STAT5 Pathway. Cells, 9.","DOI":"10.3390\/cells9020379"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10616-013-9536-8","article-title":"Daphnoretin-induced apoptosis in HeLa cells: A possible mitochondria-dependent pathway","volume":"66","author":"Yang","year":"2014","journal-title":"Cytotechnology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3892\/ol.2014.2296","article-title":"Effect of daphnoretin on the proliferation and apoptosis of A549 lung cancer cells in vitro","volume":"8","author":"Jiang","year":"2014","journal-title":"Oncol. Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.biopha.2019.01.003","article-title":"Daphnoretin: An invasion inhibitor and apoptosis accelerator for colon cancer cells by regulating the Akt signal pathway","volume":"111","author":"Yu","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.tiv.2009.06.027","article-title":"Oral small-molecule tyrosine kinase inhibitor midostaurin (PKC412) inhibits growth and induces megakaryocytic differentiation in human leukemia cells","volume":"23","author":"Huang","year":"2009","journal-title":"Toxicol. Vitr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e13122","DOI":"10.1111\/jfbc.13122","article-title":"Combinational treatment of all-trans retinoic acid (ATRA) and bisdemethoxycurcumin (BDMC)-induced apoptosis in liver cancer Hep3B cells","volume":"44","author":"Huang","year":"2020","journal-title":"J. Food Biochem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1051\/bmdcn\/2017070102","article-title":"Kuei-Lu-Er-Xian-Jiao extract enhances BMP-2 production in osteoblasts","volume":"7","author":"Wu","year":"2017","journal-title":"Biomedicine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"17858","DOI":"10.18632\/oncotarget.24909","article-title":"High levels of circulating endothelial progenitor cells in patients with diabetic retinopathy are positively associated with ARHGAP22 expression","volume":"9","author":"Huang","year":"2018","journal-title":"Oncotarget"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Liao, W.L., Lin, J.M., Liu, S.P., Chen, S.Y., Lin, H.J., Wang, Y.H., Lei, Y.J., Huang, Y.C., and Tsai, F.J. (2018). Loss of Response Gene to Complement 32 (RGC-32) in Diabetic Mouse Retina Is Involved in Retinopathy Development. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113629"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1182\/blood.V87.1.123.123","article-title":"Inhibition of protein kinase C suppresses megakaryocytic differentiation and stimulates erythroid differentiation in HEL cells","volume":"87","author":"Hong","year":"1996","journal-title":"Blood"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1182\/blood.V99.9.3220","article-title":"A functional role of Stat3 in in vivo megakaryopoiesis","volume":"99","author":"Kirito","year":"2002","journal-title":"Blood"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1182\/blood.V87.2.439.bloodjournal872439","article-title":"Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets","volume":"87","author":"Miyakawa","year":"1996","journal-title":"Blood"},{"key":"ref_36","first-page":"3509","article-title":"Thrombopoietin receptor expression in human cancer cell lines and primary tissues","volume":"55","author":"Columbyova","year":"1995","journal-title":"Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ygeno.2013.06.004","article-title":"Dynamic transcriptomes of human myeloid leukemia cells","volume":"102","author":"Wang","year":"2013","journal-title":"Genomics"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/blood.V92.10.3829.422k14_3829_3840","article-title":"Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: A novel model for chronic myelogenous leukemia","volume":"92","author":"Zhang","year":"1998","journal-title":"Blood"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/20\/3252\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:55:21Z","timestamp":1760144121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/20\/3252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,16]]},"references-count":38,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["cells11203252"],"URL":"https:\/\/doi.org\/10.3390\/cells11203252","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,16]]}}}